"Marquis Companies is a family-owned company that has proudly served seniors and their families since 1989. We customize our services and care based on the individual and offer comprehensive senior living solutions. At Marquis we offer a variety of services and living options, such as assisted living, independent cottages, post hospital care, home health care, and more. We're here to help you with your next steps, from assessing your needs and offering solutions to financing assistance and managing the transition. All Marquis facilities provide exceptional, person-centered care, with the highest quality ratings."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Marquis Forest Grove Post Acute Rehab
During the past decade, Marquis Forest Grove Post Acute Rehab conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Marquis Forest Grove Post Acute Rehab"
#1 collaborator was "Brown University" with 2 trials as a collaborator and "National Institute on Aging (NIA)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Marquis Forest Grove Post Acute Rehab
According to Clinical.Site data, the most researched conditions in "Marquis Forest Grove Post Acute Rehab" are
"Health Communication" (2 trials). Many other conditions were trialed in "Marquis Forest Grove Post Acute Rehab" in a lesser frequency.
Clinical Trials Intervention Types at Marquis Forest Grove Post Acute Rehab
Most popular intervention types in "Marquis Forest Grove Post Acute Rehab" are "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Me & My Wishes" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Marquis Forest Grove Post Acute Rehab
The vast majority of trials in "Marquis Forest Grove Post Acute Rehab" are
2 trials for "All" genders.
Clinical Trials Status at Marquis Forest Grove Post Acute Rehab
Currently, there are NaN active trials in "Marquis Forest Grove Post Acute Rehab".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Marquis Forest Grove Post Acute Rehab,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Marquis Forest Grove Post Acute Rehab, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".